ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Orphan drugs become the new favorite of pharmaceutical industry upon the huge market potential
April 07, 2017FDA approved the marketing application of Merck Serono’s Avelumab through accelerated approval on March 23, 2017, which can be said to ignite the medical circle and again draws the public interest in words like “orphan drug” and “rare disease”. -
ONCURIOUS Announces European Commission Confirmed Orphan Medicinal Product Designation for TB-403 fo
January 18, 2017ONCURIOUS NV announces that the European Commission has confirmed the orphan drug designation for TB-403 for medulloblastoma. Today's decision by the EC follows the earlier positive opinion issued by the European Medicine Agency (EMA).
Pharma Sources Insight January 2025
